VEGFA and renal cell carcinoma: For example, FBXO22 reduces tumour metastasis via the suppression of matrix metalloproteinase‐9 (MMP‐9)‐involved invasion and migration and the blockade of VEGF‐induced angiogenesis in renal cell carcinoma.45